Wolverine stack results: what to expect and when

An unapproved recovery blend with no controlled human trial of the premixed product.

Also called: Wolverine blend, BPC/TB blend.

Community blends · Unapproved BPC-157 and TB-500 mixture; ratios and ingredient identities vary.

Related uncontrolled combination exposures are not studies of a marketed fixed blend. Composition and amounts cannot be assumed equivalent. No verified fixed-blend study count is assigned.

Key studies

  • Knee pain: four combination recipients: Pain improved in 3/4 combination and 11/12 BPC-only recipients; this cannot establish benefit of a premixed blend. (source)
  • Dental nerve injury: three mixed-treatment cases: All three reported sensory improvement, but other drugs and spontaneous recovery prevent attribution to the peptides. (source)
  • Rat tendon repair: no added combination benefit: The pair did not outperform either ingredient alone in this small rat experiment. (source)
  • BPC-157: blood-vessel signals: BPC-157 increased vessel growth and VEGFR2–Akt–eNOS signaling in animal and cell experiments. (source)
  • Full-length TB4: rat skin wounds: Full-length TB4 increased wound covering in rats; this does not establish effects of the TB-500 fragment. (source)

Related to Wolverine stack (BPC-157 + TB-500)

Sources

Sources checked: 2026-10-18.

Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.